Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Bexsero“
Suchtreffer
Begriffe & Kennungen
Bexsero · 4.8 · Gastrointestinal disorders
Eintrag öffnenBexsero · 4.8 · Gastrointestinal disorders Very common: diarrhoea, vomiting (uncommon after booster)
Eintrag öffnenBexsero · 4.8 · General disorders and administration site conditions Very common: fever (≥ 38 °C), injection site tenderness (
Eintrag öffnenBexsero · 4.8 · General disorders and administration site conditions Very common: injection site pain (including severe inject
Eintrag öffnenBexsero · 4.8 · Immune system disorders Not known: allergic reactions (including anaphylactic reactions)
Eintrag öffnenBexsero · 4.8 · In addition to reports in clinical trials, worldwide voluntary reports of adverse reactions received for Bexse
Eintrag öffnenBexsero · 4.8 · In adolescents and adults, the most common local and systemic adverse reactions observed were pain at the inje
Eintrag öffnenBexsero · 4.8 · In clinical studies in infants vaccinated at 2, 4 and 6 months of age, fever (≥ 38 °C) was reported by 69% to
Eintrag öffnenBexsero · 4.8 · In infants and children (less than 2 years of age) the most common local and systemic adverse reactions observ
Eintrag öffnenBexsero · 4.8 · Metabolism and nutrition disorders Very common: eating disorders
Eintrag öffnenBexsero · 4.8 · Musculoskeletal and connective tissue disorders Very common: arthralgia
Eintrag öffnenBexsero · 4.8 · Musculoskeletal and connective tissue disorders Very common: myalgia, arthralgia
Eintrag öffnenBexsero · 4.8 · Nervous system disorders Very common: headache Not known: syncope or vasovagal responses to injection, meninge
Eintrag öffnenBexsero · 4.8 · Nervous system disorders Very common: sleepiness, unusual crying, headache Uncommon: seizures (including febri
Eintrag öffnenBexsero · 4.8 · No increase in the incidence or severity of the adverse reactions was seen with subsequent doses of the vaccin
Eintrag öffnenBexsero · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenBexsero · 4.8 · Skin and subcutaneous tissue disorders Not known: rash
Eintrag öffnenBexsero · 4.8 · Skin and subcutaneous tissue disorders Very common: rash (children aged 12 to 23 months) (uncommon after boost
Eintrag öffnenBexsero · 4.8 · Summary of the safety profile
Eintrag öffnenBexsero · 4.8 · Tabulated list of adverse reactions
Eintrag öffnen